Cargando…

Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing: A Systematic Review

SIMPLE SUMMARY: Primary culture of cancer cells from patient tumors in a physiologically relevant system can provide information about tumor biology, disentangle the role of different cell types within the tumors, and give information about drug sensitivity for the development of cancer-targeted the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Medle, Benjamin, Sjödahl, Gottfrid, Eriksson, Pontus, Liedberg, Fredrik, Höglund, Mattias, Bernardo, Carina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104249/ https://www.ncbi.nlm.nih.gov/pubmed/35565191 http://dx.doi.org/10.3390/cancers14092062

Ejemplares similares

Biological determinants of bladder cancer gene expression subtypes
por: Aine, Mattias, et al.
Publicado: (2015)

Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer—A Narrative Review
por: Sjödahl, Gottfrid, et al.
Publicado: (2022)

HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts
por: Eriksson, Pontus, et al.
Publicado: (2017)

Molecular classification of urothelial carcinoma: global mRNA classification versus tumour‐cell phenotype classification
por: Sjödahl, Gottfrid, et al.
Publicado: (2017)

Molecular pathology of the luminal class of urothelial tumors
por: Bernardo, Carina, et al.
Publicado: (2019)

A comparison of rule-based and centroid single-sample multiclass predictors for transcriptomic classification
por: Eriksson, Pontus, et al.
Publicado: (2021)

Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems
por: Eriksson, Pontus, et al.
Publicado: (2015)

Recurring urothelial carcinomas show genomic rearrangements incompatible with a direct relationship
por: Marzouka, Nour-Al-Dain, et al.
Publicado: (2020)

A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort
por: Marzouka, Nour-al-dain, et al.
Publicado: (2018)

Molecular subtype classification of urothelial carcinoma in Lynch syndrome
por: Therkildsen, Christina, et al.
Publicado: (2018)

Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma
por: Sjödahl, Gottfrid, et al.
Publicado: (2019)

Urodrill - a novel MRI-guided endoscopic biopsy technique to sample and molecularly classify muscle-invasive bladder cancer without fractionating the specimen during transurethral resection
por: Eriksson, Pontus, et al.
Publicado: (2023)

Detailed Analysis of Focal Chromosome Arm 1q and 6p Amplifications in Urothelial Carcinoma Reveals Complex Genomic Events on 1q, and SOX4 as a Possible Auxiliary Target on 6p
por: Eriksson, Pontus, et al.
Publicado: (2013)

Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma
por: Aine, Mattias, et al.
Publicado: (2015)

Low Frequency of Intratumor Heterogeneity in Bladder Cancer Tissue Microarrays
por: Jakobsson, Lovisa, et al.
Publicado: (2018)

A Systematic Study of Gene Mutations in Urothelial Carcinoma; Inactivating Mutations in TSC2 and PIK3R1
por: Sjödahl, Gottfrid, et al.
Publicado: (2011)

Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma
por: Lindgren, David, et al.
Publicado: (2012)

The Urothelial Transcriptomic Response to Interferon Gamma: Implications for Bladder Cancer Prognosis and Immunotherapy
por: Baker, Simon C., et al.
Publicado: (2022)

DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status
por: Lauss, Martin, et al.
Publicado: (2012)

FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation
por: Foth, Mona, et al.
Publicado: (2018)

Recurrent and multiple bladder tumors show conserved expression profiles
por: Lindgren, David, et al.
Publicado: (2008)

Immunohistochemical Assays for Bladder Cancer Molecular Subtyping: Optimizing Parsimony and Performance of Lund Taxonomy Classifiers
por: Hardy, Céline S.C., et al.
Publicado: (2022)

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
por: Kamoun, Aurélie, et al.
Publicado: (2019)

Latent heterogeneity of muscle‐invasive bladder cancer in patient characteristics and survival: A population‐based nation‐wide study in the Bladder Cancer Data Base Sweden (BladderBaSe)
por: Häggström, Christel, et al.
Publicado: (2023)

Re: Rakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al. A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder Cancer. NEJM Evid. In press. https://doi.org/10.1056/EVIDoa2200092
por: Liedberg, Fredrik, et al.
Publicado: (2022)

Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
por: Zhou, Zilong, et al.
Publicado: (2021)

Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors
por: Heidenblad, Markus, et al.
Publicado: (2008)

The Use of Endometrial Cancer Patient–Derived Organoid Culture for Drug Sensitivity Testing Is Feasible
por: Girda, Eugenia, et al.
Publicado: (2017)

Generation of intestinal organoids derived from human pluripotent stem cells for drug testing
por: Yoshida, Shinpei, et al.
Publicado: (2020)

Advances of Engineered Hydrogel Organoids within the Stem Cell Field: A Systematic Review
por: Li, Zheng, et al.
Publicado: (2022)

Organoid culture of bladder cancer cells
por: Yoshida, Takahiro, et al.
Publicado: (2018)

Diagnostic and prognostic implications of a three‐antibody molecular subtyping algorithm for non‐muscle invasive bladder cancer
por: Jackson, Chelsea L, et al.
Publicado: (2021)

Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
por: Olah, Csilla, et al.
Publicado: (2022)

A deep learning model for drug screening and evaluation in bladder cancer organoids
por: Zhang, Shudi, et al.
Publicado: (2023)

Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight
por: Hurst, Carolyn D., et al.
Publicado: (2021)

Human pluripotent stem-cell-derived alveolar organoids for modeling pulmonary fibrosis and drug testing
por: Kim, Jung-Hyun, et al.
Publicado: (2021)

Development of patient-derived tumor organoids and a drug testing model for renal cell carcinoma
por: Kazama, Akira, et al.
Publicado: (2021)

Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing
por: Bi, Jianling, et al.
Publicado: (2021)

Organoids are not organs: Sources of variation and misinformation in organoid biology
por: Jensen, Kim Bak, et al.
Publicado: (2023)

Test-retest reliability of the twenty-five-hole peg test in patients who had a stroke
por: Granström, Fredrik, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_argkkpm84d62984bupocukf34m